1.
Vasović D, Rašić DM, Marjanović I, Kalezić T, Lučić M. REVERSIBLE OCULAR ADVERSE EFFECTS IN MELANOMA TREATMENT WITH MEK/BRAF INHIBITORS. smclk [Internet]. 2024 Dec. 31 [cited 2026 Sep. 20];5(4). Available from: https://test.aseestant.ceon.rs/index.php/smclk/article/view/53696